Ohmori Toru 大森亨

… Alternative Names

大森亨オオモリトオル

OHMORI Tohru 大森亨

Less

Researcher Number	10276529
Affiliation (Current)	2022: 昭和大学, 医学部, 兼任講師
Affiliation (based on the past Project Information) *help	2018: 昭和大学, 医学部, 准教授 2016 – 2017: 昭和大学, 腫瘍分子生物学研究所, 准教授 2013: 昭和大学, 腫場分子生物学研究所, 准教授 2010 – 2013: 昭和大学, 腫瘍分子生物学研究所, 准教授 2012: 昭和大学, 大学共同利用機関等の部局等, 准教授
Review Section/Research Field	Principal Investigator General pharmacology Except Principal Investigator Clinical oncology / Applied pharmacology / Respiratory organ internal medicine
Keywords	Principal Investigator EGFR / TRAIL / EGFR-TKI / 薬剤耐性 / crosstalk signal / EGFR阻害剤 / c-MET / MET / FADD Except Principal Investigator 上皮成長因子受容体 … More / EGFR / 肺癌 / 喫煙者肺癌 / 扁平上皮肺癌 / 肺扁平上皮癌 / 喫煙 / ADAM17 / 扁平上皮癌 / ファーマコゲノミクス / 腫瘍壊死因子 / TNF / 発癌 / COPD / 慢性閉塞性肺疾患 Less

Investigate the role of TNF and EGFR in the onset and progression of lung cancer complicated with COPD
- Principal Investigator
  
  Yamaoka Toshimitsu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Showa University
Elucidation of trans-activation mechanism from TRAIL receptor to EGFRPrincipal Investigator
- Principal Investigator
  
  OHMORI Tohru
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General pharmacology
- Research Institution
  Showa University
Association of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced non-small cell lung cancer
- Principal Investigator
  
  HIROSE Takashi
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Tokyo National Hospital (Clinical research)
  Showa University
The role of ADAM17 in squamous cell lung cancer
- Principal Investigator
  
  SIRAI Takao
- Project Period (FY)
  2010 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  Showa University

All 2019 2018 2017 2016 2014 2013 2012 2011 2010 Other

All Journal Article Presentation Book

[Book] 薬剤耐性研究-次世代シークエンサーを用いた抗がん剤感受性予測-(142)2013
- Author(s)
  大森亨
- Total Pages
  52
- Publisher
  日本医師会雑誌
- Data Source
  KAKENHI-PROJECT-23590308
[Book] EGFR阻害剤の耐性とその克服(The mechanisms of resistance to EGFR-TKIs and challenges to overcome resistance in EGFR mutant Non-small cell lung cancer)(39巻6号)2012
- Author(s)
  山岡利光, 大森亨
- Publisher
  癌と化学療法
- Data Source
  KAKENHI-PROJECT-23590308
[Book] 薬剤耐性とその克服(改訂第3版)2012
- Author(s)
  大森亨
- Publisher
  新臨床腫学
- Data Source
  KAKENHI-PROJECT-23590308
[Book] :新臨床腫瘍学　(改訂第3版)：薬剤耐性とその克服2012
- Author(s)
  大森　亨 (分担執筆）
- Total Pages
  4
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] 67.KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR.2019
- Author(s)
  Nakatani Kaori、Yamaoka Toshimitsu、Ohba Motoi、Fujita Ken-Ichi、Arata Satoru、Kusumoto Sojiro、Taki-Takemoto Iori、Kamei Daisuke、Iwai Shinichi、Tsurutani Junji、Ohmori Tohru
- Journal Title
  
  Mol Cancer Ther
  
  Volume: 18 Pages: 112-126
- DOI
  10.1158/1535-7163.mct-18-0591
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08413, KAKENHI-PROJECT-16K09590, KAKENHI-PROJECT-17K07226
[Journal Article] Receptor Tyrosine Kinase-Targeted Cancer Therapy.2018
- Author(s)
  Yamaoka Toshimitsu、Kusumoto Sojiro、Ando Koichi、Ohba Motoi、Ohmori Tohru
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 19 Pages: 3491-3491
- DOI
  10.3390/ijms19113491
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09590, KAKENHI-PROJECT-17K07226
[Journal Article] Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure.2017
- Author(s)
  Yamaoka T, Ohba M, Arata S, Ohmori T.
- Journal Title
  
  J. Vis. Exp.
  
  Volume: 126 Pages: 1-10
- DOI
  10.3791/55967
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09590, KAKENHI-PROJECT-17K07226
[Journal Article] Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation.2017
- Author(s)
  Yamaoka T, Ohmori T, Ohba M, Arata S, Murata Y, Kusumoto S, Ando K, Ishida H, Ohnishi T, Sasaki Y.
- Journal Title
  
  Mol Cancer Res.
  
  Volume: 7 Pages: 915-928
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09590
[Journal Article] Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.2017
- Author(s)
  Yamaoka T, Ohba M, Ohmori T.
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 18 Pages: 2420-2442
- DOI
  10.3390/ijms18112420
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09590, KAKENHI-PROJECT-17K07226
[Journal Article] Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation.2016
- Author(s)
  64.Yamaoka T., Ohmori T., Ohba M., Arata S., Kishino Y., Murata Y., Kusumoto S., Ishida H., Shirai T., Hirose T., Ohnishi T., and Sasaki Y.
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 15 Pages: 3040-3054
- DOI
  10.1158/1535-7163.mct-16-0313
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460153, KAKENHI-PROJECT-16K09590
[Journal Article] Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients : A prospective study2014
- Author(s)
  Hiroaki Ito, Tohru Ohmori, et al
- Journal Title
  
  Int J Oncol
  
  Volume: 45 Pages: 227-234
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Prognostic impact of the number of viable circulating2014
- Author(s)
  Ito H, Ohmori T et al
- Journal Title
  
  INTERNATIONAL JOURNAL OF ONCOLOGY
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] EGFR阻害剤の耐性とその克服 (The mechanisms of resistance to EGFR-TKIs and challenges to overcome resistance in EGFR mutant Non-small cell lung cancer)2012
- Author(s)
  山岡利光, 大森　亨
- Journal Title
  
  癌と化学療法
  
  Volume: 39 Pages: 857-862
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] 進行再発非小細胞肺癌に対するセカンドライン化学療法の検討2012
- Author(s)
  白井崇生, 慶瀬敬, 村田泰規, 大木康成, 楠本壮三郎, 杉山智英, 石田博雄, 中属賢尚, 大西司, 山岡利光, 大森亨, 奥田健太郎
- Journal Title
  
  昭和医学会雑誌
  
  Volume: 72巻4号 Pages: 446-452
- NAID
  130003378205
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer.2012
- Author(s)
  Hirose T, Murata Y, Oki Y, Sugiyama T, Kusumoto S, Ishida H, Shirai T, Nakashima M, Yamaoka T, Okuda K, Ohnishi T, Ohmori T.
- Journal Title
  
  Oncology Research
  
  Volume: 20 Pages: 131-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer2012
- Author(s)
  Hirose T, Yamaoka T, Ohmori T. et al
- Journal Title
  
  Oncol Res
  
  Volume: 20(2-3) Pages: 131-137
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease2012
- Author(s)
  Okuda K, Hirose T, Yamaoka T, Ohmori T. et al
- Journal Title
  
  Anticancer Res
  
  Volume: 32(2) Pages: 5475-5480
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease2012
- Author(s)
  Okuda K, Hirose T, Oki Y, Murata Y, Kusumoto S, Sugiyama T, Ishida H, Shirai T, Nakashima M, Yamaoka T, Ohnishi T, Ohmori T
- Journal Title
  
  Anticancer Res.
  
  Volume: 32(12) Pages: 5475-80
- URL
  http://ar.iiarjournals.org/content/32/12/5475.long
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Application of a qualitative and quantitative real-time polymerase chain reaction method for detecting genetically modified papaya line 55-1 in papaya products.2012
- Author(s)
  Sakai A, Kasahara K, Ohmori T, Kimura H, Sone T, Fujimura M, Nakao S.
- Journal Title
  
  Journal of Thorac Oncology
  
  Volume: 9 Pages: 1337-44
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Application of a qualitative and quantitative real-time polymerase chain reaction method for detecting genetically modified papaya line 55-1 in papaya products2012
- Author(s)
  Sakai A, Ohmori T, et al
- Journal Title
  
  J Thorac Oncol
  
  Volume: 9 Pages: 1337-1344
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer2012
- Author(s)
  Hirose T, Murata Y, Oki Y, Sugiyama T, Kusumoto S, Ishida H, Shirai T, Nakashima M, Yamaoka T, Okuda K, Ohnishi T, Ohmori T
- Journal Title
  
  Oncol Res.
  
  Volume: 20(2-3) Pages: 131-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.2012
- Author(s)
  Okuda K, Hirose T, Oki Y, Murata Y, Kusumoto S, Sugiyama T, Ishida H, Shirai T, Nakashima M, Yamaoka T, Ohnishi T, Ohmori T.
- Journal Title
  
  Anticancer Researcg
  
  Volume: 32 Pages: 1337-44
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer.2011
- Author(s)
  Murata Y, Hirose T, Ohmori T et al
- Journal Title
  
  Eur J Cancer
  
  Volume: 47 Pages: 1336-42
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/21458256
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer2011
- Author(s)
  Hirose T, Yamaoka T, Ohmori T, et al
- Journal Title
  
  Lung Cancer
  
  Volume: (Epub ahead of print)
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.2011
- Author(s)
  Oki Y, Hirose T, Ohmori T et al
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 67 Pages: 791-7
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/20556612
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small -cell lung cancer2011
- Author(s)
  Hirose T, Nakashima M, Shirai T, Kusumoto S, Sugiyama T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Adachi M
- Journal Title
  
  Lung Cancer
  
  Volume: 73(3) Pages: 345-50
- DOI
  10.1016/j.lungcan.2010.12.015
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer2011
- Author(s)
  Oki Y, Hirose T, Yamaoka T, Ohmori T, et al
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 67(4) Pages: 791-797
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small -cell lung cancer2011
- Author(s)
  Murata Y, Hirose T, Yamaoka T, Shirai T, Okuda K, Sugiyama T, Kusumoto S, Nakashima M, Ohmori T, Adachi M
- Journal Title
  
  Eur J Cancer
  
  Volume: 47(9) Pages: 1336-42
- DOI
  10.1016/j.ejca.2011.03.007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer2011
- Author(s)
  Murata Y, Hirose T, Yamaoka T, Ohmori T, et al
- Journal Title
  
  Eur J Cancer
  
  Volume: 47(9) Pages: 1336-1342
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer2011
- Author(s)
  Sugiyama T, Hirose T, Ohmori T et al
- Journal Title
  
  Oncology
  
  Volume: 81 Pages: 273-80
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22122886
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small -cell lung cancer?2011
- Author(s)
  Hirose T, Okuda K, Yamaoka T, Ishida K, Kusumoto S, Sugiyama T, Shirai T, Ohnshi T, Ohmori T, Adachi M
- Journal Title
  
  Lung Cancer
  
  Volume: 71(2) Pages: 224-8
- DOI
  10.1016/j.lungcan.2010.05.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer.2011
- Author(s)
  Hirose T, Ohmori T et al
- Journal Title
  
  Lung Cancer
  
  Volume: 73 Pages: 345-50
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/21277039
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?2011
- Author(s)
  Hirose T, Yamaoka T, Ohmori T, et al
- Journal Title
  
  Lung Cancer
  
  Volume: 71(2) Pages: 224-228
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] Phase II study of S-1,a novel oral fluoropyrimidine,and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer2011
- Author(s)
  Oki Y, Hirose T, Yamaoka T, Kusumoto S, Shirai T, Sugiyama T, Okuda K, Nakashima M, Murata Y, Ohmori T, Adachi M
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 67(4) Pages: 791-7
- DOI
  10.1007/s00280-010-1382-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer2011
- Author(s)
  Sugiyama T, Hirose T, Yamaoka T, Ohmori T, et al
- Journal Title
  
  Oncology
  
  Volume: 81(3-4) Pages: 273-280
- Data Source
  KAKENHI-PROJECT-23590308
[Journal Article] The UGT1A1*28 genotype and the toxicity of low -dose irinotecan in patients with advanced lung cancer2010
- Author(s)
  Sugiyama T, Hirose T, Kusumoto S, Shirai T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Adachi M
- Journal Title
  
  Oncol Res.
  
  Volume: 18(7) Pages: 337-42
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] KRAS amplification mediates resistance to osimertinib in acquired afatinib-resistant NSCLC harboring exon 19 deletion/T790M in EGFR2019
- Author(s)
  Toshimitsu Yamaoka, Motoi Ohba, Yasunari Kishino, Sojiro Kusumoto, Junji Tsurutani, Tohru Ohmori
- Organizer
  AACR 110th Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] GFR遺伝子変異陽性(exon19del/T790M)肺腺癌細胞株におけるオシメルチニブ獲得耐性機序2019
- Author(s)
  山岡利光, 岸野康成, 楠本壮二郎, 鶴谷純司, 相良博典, 大森亨
- Organizer
  第59回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] T790M-EGFRによりアファチニブ耐性をきたした肺腺癌細胞株におけるロシレチニブ耐性機序の検討2018
- Author(s)
  山岡利光,楠本壮二郎,安藤浩一,石田博雄,大西司,相良博典,大森亨
- Organizer
  第59回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] EGFR-T790Mを発現した肺腺癌細胞における第３世代EGFR-TKI,ロシレチニブの獲得耐性機序の検討2018
- Author(s)
  山岡利光,中谷香織, 大場基, 藤田健一, 岩井信市, 大森亨
- Organizer
  第76回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] 次元培養法を用いたキナーゼ阻害剤の感受性評価.2018
- Author(s)
  伊東里紗, 鈴木俊宏, 山岡利光, 大森亨, 西尾和人, 小笠原裕樹
- Organizer
  第76回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] EGFR-Mutationを伴う肺腺癌細胞株におけるEGFR-TKIとMET-TKIへの獲得耐性機序2017
- Author(s)
  山岡利光　大森亨　大場基　村田泰規　大木康成　楠本壮二郎　大西司　相良博典
- Organizer
  第57回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation2017
- Author(s)
  山岡利光　大場基　荒田悟　大森亨
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] EGFR遺伝子変異を有する肺腺癌細胞株PC-9におけるafatinib獲得耐性機序の検討2017
- Author(s)
  山岡利光　大場基　荒田悟　大森亨
- Organizer
  第58回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] EGFR-Mutationを伴う肺腺癌細胞株におけるEGFR-TKIとMET-TKIへの獲得耐性機序2016
- Author(s)
  山岡利光, 大森亨, 大場基, 村田泰規, 楠本壮二郎, 石田博雄, 佐々木康綱
- Organizer
  日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-07
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] Mechanism underlying acquisition of dual resistance to EGFR and MET inhibitors by EGFR-mutant lung adenocarcinoma cells2016
- Author(s)
  Yamaoka T, Ohmori T, Ohba M, Kishino Y, Murata Y, Kusumoto S, Ishida H, Ohnishi T, Sasaki Y.
- Organizer
  AACR
- Place of Presentation
  ニューオリンズ・米国
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] Mechanism underlying acquisition of dual resistance to EGFR and MET inhibitors by EGFR-mutant lung adenocarcinoma cells2016
- Author(s)
  山岡利光, 大森亨, 大場基, 村田泰規, 楠本壮二郎, 石田博雄, 佐々木康綱
- Organizer
  臨床腫瘍学会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-16K09590
[Presentation] Contribution of miR-205 in gefitinib-resistant lung cancer cell lines.2014
- Author(s)
  Suzuki T, Ohmori T et al
- Organizer
  Annual Meeting 2014, American Association for Cancer Research
- Place of Presentation
  SanDiego, CA
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Contribution of miR-205 in gefitinib-resistant lung cancer cell lines2014
- Author(s)
  Toshihiro Suzuki, Toshimitsu Yamaoka, Tohru Ohmori, et al
- Organizer
  Annual Meeting 2014
- Place of Presentation
  American Association for Cancer Research SanDiego
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] TNF transactivation of EGFR protects EGFR-TKI, gefitinib induced pulmonary epithelial cell apoptosis and injury in TNF transgenic mice2014
- Author(s)
  Toshimitsu Yamaoka, Tohru Ohmori, et al
- Organizer
  Annual Meeting 2014
- Place of Presentation
  American Association for Cancer Research SanDiego(#2277)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Tivantinib shows a synergistic growth-inhibitory effect with erlotinib through enhanced degradation of c-MET protein2014
- Author(s)
  大森　亨、山岡利光　他
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] TNF transactivation of EGFR protects EGFR-TKI, gefitinib induced pulmonary epithelial cell apoptosis and injury in TNF transgenic mice.2014
- Author(s)
  Yamaoka T, Ohmori T et al
- Organizer
  Annual Meeting 2014, American Association for Cancer Research
- Place of Presentation
  SanDiego, CA
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] A novel c-MET inhibitor, tivantinib, shows an additive growth-inhibitory effect with erlotinib through enhanced degradation of c-MET protein via its recycling pathway2013
- Author(s)
  Tohru Ohmori, Toshimitsu Yamaoka, Takashi Hirose, et al
- Organizer
  19^<th> International Charles Heidelberger Symposium on Cancer Research
- Place of Presentation
  鹿児島(P-04)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] MET高感受性を示すEGFR-TKI耐性PC-9細胞におけるMET阻害剤耐性細胞株の樹立/The characteristics of dual resistance to EGFR & MET inhibitors in pulmonary adenocarcinoma, PC-9 cells2013
- Author(s)
  山岡利光, 大森亨, 他
- Organizer
  PC-9 cells第72回日本癌学会学術総会
- Place of Presentation
  横浜(E-2030)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Clinical benefit of 2nd EGFR-TKI retreatment on overall survival in patients with advanced non-small cell lung cancer2013
- Author(s)
  Masanao Nakashima, Takashi Hirose, Toshimitsu Yamaoka, Tohru Ohmori, et al
- Organizer
  第11回日本臨床腫瘍学会学術集会
- Place of Presentation
  仙台(P-1413)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 表面増強ラマン散乱（SERS）を用いた新しいオミックス解析技術の開発／Novel methodology of integrated omics analysis by using Surface Enhanced Raman Scattering (SERS): A Preliminary Study2013
- Author(s)
  伊藤寛晃、大森　亨　他
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] The characteristics of an acquired dual resistance to EGFR & MET inhibitors in non-small cell lung cancer, harboring active mutation of EGFR.2013
- Author(s)
  Yamaoka T, Ohmori T et al
- Organizer
  Annual Meeting 2013, American Association for Cancer Research
- Place of Presentation
  Washington, DC
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 非小細胞肺癌におけるエルロチニブとゾレドロン酸併用療法の有用性に関する後方視的解析2013
- Author(s)
  大木康成, 廣瀬敬, 白井崇生, 村田泰規, 杉山智英, 楠本壮二郎, 石田博雄, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 相良博典
- Organizer
  肺癌学会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] The Characteristics of an acquired dual resistance to EGFR & MET inhibitors in non-small cell lung cancer, harbouring active mutation of EGFR2013
- Author(s)
  山岡利光, 市橋陽子, 村田泰規, 大木康成, 杉山智英, 石田博雄, 白井崇生, 廣瀬敬,中嶌賢尚, 奥田健太郎, 大西司, 大森亨
- Organizer
  米国癌学会 (AACR)
- Place of Presentation
  ワシントンDC
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] The characteristics of an acquired dual resistance to EGFR & MET inhibitors in non-small cell lung cancer, harboring active mutation of EGFR2013
- Author(s)
  Toshimitsu Yamaoka, Takashi Hirose, Tohru Ohmori et al
- Organizer
  #5648Annual Meeting 2013
- Place of Presentation
  American Association for Cancer Research Washington
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 非小細胞肺癌におけるエルロチニプとゾレドロン酸併用療法の有用性に関する後方視的解析2013
- Author(s)
  大木康成, 慶瀬敬, 白井崇生, 村田泰規, 杉山智英, 楠本壮三郎, 石田博雄, 中属賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 相良博典
- Organizer
  日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2013-11-21
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 小細胞肺癌患者における末梢血中がん細胞数と予後の検討2013
- Author(s)
  白井崇生, 慶瀬敬, 村田泰規, 大木康成, 楠本壮三郎, 杉山智英, 石田博雄, 中属賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 相良博典
- Organizer
  日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2013-11-21
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] The Characteristics of dual resistance to EGFR & MET inhibitors in pulmonary adenocarcinoma, PC-9 cells2013
- Author(s)
  山岡利光, 杉山智英, 石田博雄, 白井崇生, 奥田健太郎, 外谷衣都子, 大場基, 大森亨, 佐々木康綱
- Organizer
  日本癌学会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] MET高感受性を示すEGFR-TKI耐性PC-9細胞におけるMET阻害剤耐性細胞株の樹立／The characteristics of dual resistance to EGFR & MET inhibitors in pulmonary adenocarcinoma, PC-9 cells2013
- Author(s)
  山岡利光、大森　亨　他
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 表面増強ラマン散乱(SERS)を用いた新しいオミックス解析技術の開発/Novel methodology of integrated omics analysis by using Surface Enhanced Raman Scattering (SERS): A Preliminary Study2013
- Author(s)
  伊藤寛晃, 大森亨, 他
- Organizer
  A Preliminary Study第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 循環癌細胞の個別採取と増幅抽出ゲノムDNAの次世代シークエンサーによる網羅的遺伝子解析2013
- Author(s)
  伊藤寛晃, 大森亨, 他
- Organizer
  第113回日本外科学会(福岡)
- Place of Presentation
  京都(ポスターセッション(375)新規治療法開発遺伝子解析)
- Year and Date
  2013-04-01
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Clinical benefit of 2nd EGFR-TKI retreatment on overall survival in patients with advanced non-small cell lung cancer2013
- Author(s)
  Nakashima M, Ohmori T et al
- Organizer
  第11回日本臨床腫瘍学会学術集会
- Place of Presentation
  仙台
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 小細胞肺癌患者における末梢血中がん細胞数と予後の検討2013
- Author(s)
  白井崇生, 廣瀬敬, 村田泰規, 大木康成, 楠本壮二郎, 杉山智英, 石田博雄, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 相良博典
- Organizer
  肺癌学会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 脳転移を伴うEML4-ALK融合遺伝子陽性非小細胞肺癌に対しクリゾチニブを投与した2症例の検討2013
- Author(s)
  石田博雄, 村田泰規, 大木康成, 石田孔子, 白井崇生, 山岡利光, 大西司, 大森亨, 相良博典, 佐々木康綱
- Organizer
  肺癌学会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] EGFR遺伝子変異陽性肺腺癌患者に対するゲフィチニブとゾレドロン酸併用療法の有用性に関する後方視的解析2012
- Author(s)
  大木康成, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page625)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] FGFR-TKIの再投与の有効性と安全性の検討2012
- Author(s)
  中嶌賢尚, 大木康成, 村田泰規, 石田孔子, 杉山智英, 石田博雄, 白井崇生, 山岡利光, 奥田健太郎, 大森亨, 大西司, 廣瀬敬
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] EGFR遺伝子変異陽性肺腺癌患者に対するゲフィチニブとゾレドロン酸併用療法の有用性に関する後方視的解析2012
- Author(s)
  大木康成, 廣瀬敬, 村田泰規, 杉山智英, 楠本壮二郎, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 糖尿病合併肺癌の現状について2012
- Author(s)
  楠本壮二郎, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (日本呼吸器学会誌1巻増刊Page319)
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Micro RNAによるゲフィチニブ耐性関連因子の調節2012
- Author(s)
  鈴木俊宏, 大森亨, 他
- Organizer
  第16回日本がん分子標的治療学会(S2-4)
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 切除不能局所進行非小細胞肺癌に対する胸部放射線療法とvinorelbine, carboplatin同時併用第II相試験2012
- Author(s)
  廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (日本呼吸器学会誌1巻増刊Page326)
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Carboplatin+Paclitaxel+Bevacizumabによる化学療法中にIII度房室ブロックをきたした肺腺癌症例2012
- Author(s)
  白井崇生, 廣瀬敬, 大木康成, 村田泰規, 楠本壮二郎, 杉山智英, 石田博雄, 中嶌賢尚, 奥田健太郎, 大西司, 足立満, 山岡利光, 大森亨
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 当院におけるCOPD合併切除不能非小細胞肺癌に関する検討2012
- Author(s)
  杉山智英, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page775)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] FGFR-TKIの再投与の有効性と安全性の検討.2012
- Author(s)
  中嶌賢尚, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page621)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 切除不能局所進行非小細胞肺癌に対する胸部放射線療法とvinorelbine, carboplatin同時併用第II相試験2012
- Author(s)
  大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page579)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 当院におけるCOPD合併切除不能非小細胞肺癌に関する検討2012
- Author(s)
  杉山智英, 廣瀬敬, 大木康成, 村田泰規, 楠本壮二郎, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 濱田健司
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Cancer Vaccination trial with novel multiple peptides in previously treated advanced non-small cell lung cancer.2012
- Author(s)
  Takashi Hirose, Hidehiro Noda, Tohru Ohmori et al
- Organizer
  Annual Meeting of American Society of Clinical Oncology 2012
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] SPC/TNFトランスジエニックマウスモデルにおけるEGFRチロシンキナーゼ阻害剤による肺組織のアポトーシス誘導機構の検討2012
- Author(s)
  山岡利光, 大木康成, 村田泰規, 杉山智英, 石田博雄, 白井崇生, 中属賢尚, 奥田健太郎, 大西司, 慶瀬敬, 大森亨
- Organizer
  日本呼吸器学会学術集会
- Place of Presentation
  東京
- Year and Date
  2012-04-19
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 進展型小細胞肺癌の生存期間に対するアムルビシンの影響に関する検討2012
- Author(s)
  石田博雄, 大木康成, 村田泰規, 石田孔子, 楠本壮二郎, 杉山智英, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 廣瀬敬
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 気道上皮細胞と非小細胞肺癌細胞におけるTACEを介したTNFによるEGFRのトランス活性化機序の検討2012
- Author(s)
  山岡利光, 村廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (日本呼吸器学会誌1巻増刊Page323)
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Micro RNAによるゲフィチニブ耐性関連因子の調節2012
- Author(s)
  鈴木俊宏、入澤　愛、西尾和人、大森　亨、兎川忠靖、櫻庭　仁
- Organizer
  第16回日本がん分子標的治療学会
- Place of Presentation
  福岡　北九州
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 高齢者進行非小細胞肺癌のnedaplatin+gemcitabine併用療法の有効性と安全性のレトロスペクティブ検討2012
- Author(s)
  山岡利光, 村田泰規, 大木康成, 楠本壮二郎, 杉山智英, 白井崇生, 中嶌賢尚, 奥田健太郎, 大西司, 大森亨, 廣瀬敬, 足立満
- Organizer
  日本呼吸器学会
- Place of Presentation
  兵庫、神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 当院におけるCOPD合併肺癌手術例に関する検討2012
- Author(s)
  杉山智英, 廣瀬敬, 村田泰規, 大木康成, 楠本壮二郎, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 門倉光隆, 大森亨, 足立満
- Organizer
  日本呼吸器学会
- Place of Presentation
  兵庫、神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 高齢者小細胞肺癌に対する治療成績の検討2012
- Author(s)
  村田泰規, 廣瀬敬, 大木康成, 杉山智英, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Carboplatin+Paclitaxel+Bevacizumabによる化学療法中にIII度房室プロックをきたした肺腺癌症例2012
- Author(s)
  白井崇生, 慶瀬敬, 大木康成, 村田泰規, 楠本壮三郎, 杉山智英, 石田博雄, 中属賢尚, 奥田健太郎, 大西司, 足立満, 山岡利光, 大森亨
- Organizer
  日本肺癌学会
- Place of Presentation
  岡山
- Year and Date
  2012-11-08
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] A novel c-MET inhibitor, tivantinib, shows an additive growth-inhibitory effect with erlotinib through enhanced degradation of c-MET protein via its recycling pathway2012
- Author(s)
  210. Tohru Ohmori, Tomoko Kanome, Toshimitsu Yamaoka, Takashi Hirose, Fumiaki Koizumi, Kazuto Nishio, Shiro Akinaga
- Organizer
  19th International Charles Heidelberger Symposium on Cancer Research
- Place of Presentation
  鹿児島
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 標準治療不応進行非小細胞肺癌に対するペプチドワクチン療法(Cancer vaccination trial with novel mult iple peptides in previously treated advanced non-small-cell lung cancer (NSCLC))2012
- Author(s)
  慶瀬敬, 野田秀裕, 奥田健太郎, 阿部誠治, 大戸祐治, 杉山智英, 石田博雄, 白井崇生, 中属賢尚, 山岡利光, 大森亨, 吉田浩三, 中村祐輔
- Organizer
  日本癌学会
- Place of Presentation
  札幌
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] Specific epidermal growth factor receptor autophosphorylation sites promote epithelial cell chemotaxis and restitution2012
- Author(s)
  Tohru Ohmori, Toshimitsu Yamaoka, Takashi Hirose, et al
- Organizer
  103rd Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Chicago
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 切除不能局所進行非小細胞肺癌に対する胸部放射線療法とvinorelbine、carboplatin同時併用第II相試験2012
- Author(s)
  廣瀬敬, 村田泰規, 大木康成, 杉山智英, 楠本壮二郎, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨
- Organizer
  第53回日本肺癌学会総会
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] HSP 70 may cause EGFR-TKIs-resistance due to inhibit drug binding to EGFR in the cells that expressed mutant EGFR2012
- Author(s)
  Tohru Ohmori, Tsuyoki Kadofuku, Yoko Ichihashi, Toshimitsu Yamaoka, Takashi Hirose, Mitsuru Adachi, Nagahiro Saijo
- Organizer
  103rd Meeting of American Association for Cancer Research
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Carboplatin+Paclitaxel+ Bevacizumabによる化学療法中にIII度房室ブロックをきたした肺腺2012
- Author(s)
  白井崇生, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (癌症例肺癌52巻3号Page359-360)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 糖尿病合併肺癌の現状について2012
- Author(s)
  楠本壮二郎, 大木康成, 村田泰規, 杉山智英, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 廣瀬敬, 大西司, 大森亨, 足立満
- Organizer
  日本呼吸器学会
- Place of Presentation
  兵庫、神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 進展型小細胞肺癌の生存期間に対するアムルビシンの影響に関する検討2012
- Author(s)
  石田博雄, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page586)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Specific epidermal growth factor receptor autophosphorylation sites promote epithelial cell chemotaxis and restitution2012
- Author(s)
  Toshimitsu Yamaoka, Mark Frey, D. Brent Polk, Tohru Ohmori et al
- Organizer
  103rd Meeting of American Association for Cancer Research
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Cancer Vaccination trial with novel multiple peptides in previously treated advanced non-small cell lung cancer2012
- Author(s)
  Tohru Ohmori, Toshimitsu Yamaoka, Takashi Hirose, et al
- Organizer
  Annual Meeting of American Society of Clinical Oncology
- Place of Presentation
  Chicago
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 高齢者進行非小細胞肺癌のnedaplatin+gemcitabine併用療法の有効性と安全性のレトロスペクティブ検討2012
- Author(s)
  中嶌賢尚, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (日本呼吸器学会誌1巻増刊Page264)
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 進展型小細胞肺癌の生存期間に対するアムルビシンの影響に関する検討2012
- Author(s)
  石田博雄, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (日本癌治療学会誌47巻3号Page2134)
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 高齢者小細胞肺癌に対する治療成績の検討2012
- Author(s)
  村田泰規, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page637)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 進行肺大細胞神経内分泌癌と進展型小細胞肺癌に対する化学療法の有効性の比較2012
- Author(s)
  石田博雄, 大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  (肺癌52巻5号Page598)
- Place of Presentation
  岡山
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 進展型小細胞肺癌の生存期間に対するアムルビシンの影響に関する検討2012
- Author(s)
  202. 石田博雄, 大木康成, 村田泰規, 石田孔子, 楠本壮二郎, 杉山智英, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 廣瀬敬
- Organizer
  第50回日本癌治療学会総会
- Place of Presentation
  神奈川、横浜
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] HSP 70 may cause EGFR-TKIs-resistance due to inhibit drug binding to EGFR in the cells that expressed mutant EGFR2012
- Author(s)
  Tohru Ohmori, Toshimitsu Yamaoka, Takashi Hirose, et al
- Organizer
  Proceedings of American Association for Cancer Research, #1900
- Place of Presentation
  Chicago
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 切除不能局所進行非小細胞肺癌に対する胸部放射線療法とvinorelbine、carboplatin同時併用第II相試験2012
- Author(s)
  廣瀬敬, 大木康成, 村田泰規, 杉山智英, 楠本壮二郎, 石田博雄, 白井崇生, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 足立満
- Organizer
  日本呼吸器学会
- Place of Presentation
  兵庫、神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] EGFR遺伝子変異陽性の肺腺癌患者に対する、ゲフィチニプとゾレドロン酸併用療法の有用性に関する後方視的解析2012
- Author(s)
  大木康成, 村田泰規, 杉山智英, 楠本壮三郎, 石田博雄, 白井崇生, 中属賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 慶瀬敬
- Organizer
  日本呼吸器学会学術集会
- Place of Presentation
  東京
- Year and Date
  2012-04-19
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 当院におけるCOPD合併肺癌手術例に関する検討2012
- Author(s)
  杉山智英, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (日本呼吸器学会誌1巻増刊Page326)
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 当院におけるCOPD合併肺癌手術例に関する検討2011
- Author(s)
  杉山智英, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (肺癌51巻5号Page516)
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] HSP70 may cause EGFR-TKIs-resistance due to inhibit drug binding to EGFR in the cell that expressed mutant EGFR2011
- Author(s)
  Tohru Ohmori, Toshimitsu Yamaoka, Takashi Hirose, et al
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋(English oral session E-1017)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 超高齢者進行非小細胞肺癌の治療の有用性と安全性について2011
- Author(s)
  奥田健太郎, 廣瀬敬, 山岡利光, 大森亨, 他
- Place of Presentation
  東京(日本呼吸器学会雑誌49巻増刊Page294)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] HSP70 specifically binds to 15 bp deletion mutant EGFR and modulates sensitivity to EGFR-TKI2011
- Author(s)
  Tsuyoki Kadofuku, Toshimitsu Yamaoka, Takashi Hirose, Tohru Ohmori, et al
- Place of Presentation
  Orland FL, USA(Proceedings of American Association for Cancer Research, Vol. 52 699)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] EGFR-TKI耐性細胞に対するARQ197のMet阻害機構2011
- Author(s)
  大森　亨、鹿目知子、et al
- Organizer
  第15回がん分子標的治療研究会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 高齢者進行非小細胞肺癌に対するnedaplatin +gemcitabine併用療法の有効性と安全性の検討2011
- Author(s)
  中嶌賢尚, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (肺癌51巻5号Page486)
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] EGFR-TKI耐性細胞に対するARQ197のMet阻害機構2011
- Author(s)
  大森亨, 山岡利光, 廣瀬敬, 他
- Organizer
  第15回がん分子標的治療研究会総会
- Place of Presentation
  東京(ワークショップW6-4)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Expression study of micro RNA in Gefitinib resistant cell lines2011
- Author(s)
  Ai Irisawa,, Tohru Ohmori, T et al
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋(P-2095)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] HSP70 may cause EGFR-TKIs-resistance due to inhibit drug binding to EGFR in the cell that expressed mutant EGFR2011
- Author(s)
  Tohru Ohmori, Tsuyoki Kadofuku　et al
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 糖尿病合併肺癌の現状について2011
- Author(s)
  楠本壮二郎, 廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (肺癌51巻5号Page495)
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] Expression study of micro RNA in Gefitinib resistant cell lines2011
- Author(s)
  Ai Irisawa, Tohihiro Suzuki, Tohru Ohmori　et al
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] IV期非小細胞肺がんにおける末梢血中がん細胞数(CTC)と抗がん剤治療の効果と予後との関連性2011
- Author(s)
  廣瀬敬, 山岡利光, 大森亨, 他
- Organizer
  (肺癌51巻5号Page421)
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 再発あるいは前治療無効小細胞肺癌(SCLC)に対するamrubicin, carboplatin併用第II相試験2011
- Author(s)
  廣瀬敬, 山岡利光, 大森亨, 他
- Place of Presentation
  東京(日本呼吸器学会雑誌49巻増刊Page295)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 発熱性好中球減少症におけるプロカルシトニンの有用性の検討2011
- Author(s)
  杉山智英, 廣瀬敬, 山岡利光, 大森亨, 他
- Place of Presentation
  東京(日本呼吸器学会雑誌49巻増刊Page162)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 気道上皮細胞と非小細胞肺癌細胞におけるTACE/EGFR-リガンドを介したTNFによるEGFRのトランス活性化の機序検討(TNF transactivates phospho-tyrosine 1068 of EGFR through TACE/EGFR-ligand dependent mechanism)2011
- Author(s)
  山岡利光, 大木康成, 楠本壮三郎, 杉山智英, 白井崇生, 中属賢尚, 奥田健太郎, 慶瀬敬, 大森亨, 大西司, 足立満
- Organizer
  日本癌学会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] TNF transactivates phospho-tyrosine 1068 of EGFR through TACE/EGFR-ligand dependent mechanism2011
- Author(s)
  Toshimitsu Yamaoka, Takashi Hirose, Tohru Ohmori, et al
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋(P-2051)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 気道上皮細胞と肺癌細胞におけるTNFによるEGFRトランス活性化に寄与するリガンドの同定とアポトーシス制御機構2011
- Author(s)
  山岡利光, 大森亨, 廣瀬敬, 他
- Place of Presentation
  東京(日本呼吸器学会雑誌49巻増刊Page159)
- Data Source
  KAKENHI-PROJECT-23590308
[Presentation] 進行非小細胞肺癌の生存期間が延長しているのはなぜか?2010
- Author(s)
  白井崇生, 慶瀬敬, 楠本壮三郎, 杉山智英, 中属賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 足立満
- Organizer
  日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2010-11-12
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 非小細胞肺癌に対するエルロチニブの毒性に影響を与える薬物動態、薬理遺伝学的検討
- Author(s)
  廣瀬敬, 藤田健一, 楠本壮二郎, 白井崇生, 村田泰則, 大木康成, 杉山智英, 石田博雄, 中嶌賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 佐々木康綱, 田村厚久, 大田健
- Organizer
  第54回日本呼吸器学会
- Data Source
  KAKENHI-PROJECT-23590648
[Presentation] ssociation of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced NSCLC
- Author(s)
  Takashi Hirose, Ken-ichi Fujita, Sojiro Kusumoto, Takao Shirai, Tomohide Sugiyama, Masanao Nakashima, Tohru Ohmori, Yasutsuna Sasaki, Atsuhisa Tamura , Ken Ohta
- Organizer
  第12回臨床腫瘍学会
- Data Source
  KAKENHI-PROJECT-23590648

1. YAMAOKA Toshimitsu (40384359)

# of Collaborated Projects: 4 results

# of Collaborated Products: 104 results
2. HIROSE Takashi (40307038)

# of Collaborated Projects: 3 results

# of Collaborated Products: 81 results
3. ADACHI Mitsuru (10095870)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
4. 佐々木康綱 (20235279)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
5. SIRAI Takao (90384362)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
6. KADOKURA Mitsutaka (60214417)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 藤田健一 (60281820)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
8. 荒田悟 (20159502)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
9. 本間まゆみ (20527171)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 楠本壮二郎 (30465091)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
11. 中嶌賢尚 (90365768)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. KAMEI Daisuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 大場基

# of Collaborated Projects: 0 results

# of Collaborated Products: 5 results

Ohmori Toru 大森 亨

大森 亨 オオモリ トオル

OHMORI Tohru 大森 亨

Research Projects

Research Products

Co-Researchers

Investigate the role of TNF and EGFR in the onset and progression of lung cancer complicated with COPD

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of trans-activation mechanism from TRAIL receptor to EGFRPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Association of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced non-small cell lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of ADAM17 in squamous cell lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 薬剤耐性研究-次世代シークエンサーを用いた抗がん剤感受性予測-(142)2013

Author(s)

Total Pages

Publisher

Data Source

[Book] EGFR阻害剤の耐性とその克服(The mechanisms of resistance to EGFR-TKIs and challenges to overcome resistance in EGFR mutant Non-small cell lung cancer)(39巻6号)2012

Author(s)

Publisher

Data Source

[Book] 薬剤耐性とその克服(改訂第3版)2012

Author(s)

Publisher

Data Source

[Book] :新臨床腫瘍学 (改訂第3版)： 薬剤耐性とその克服2012

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] 67.KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Receptor Tyrosine Kinase-Targeted Cancer Therapy.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation.2017

Author(s)

Journal Title

Data Source

[Journal Article] Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients : A prospective study2014

Author(s)

Journal Title

Ohmori Toru 大森亨

大森亨オオモリトオル

OHMORI Tohru 大森亨

[Book] :新臨床腫瘍学　(改訂第3版)：薬剤耐性とその克服2012